Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma Kun-Ming Chung, Sheng-Tsung Chang, Wen-Tsung Huang, Chin-Li Lu, Hung-Chang Wu, Wei-Shou Hwang, Kwang-Yu Chang, Shih- Sung Chuang Journal of the Formosan Medical Association Volume 112, Issue 7, Pages 382-389 (July 2013) DOI: 10.1016/j.jfma.2012.07.031 Copyright © 2012 Terms and Conditions
Figure 1 Overall survival curves of patients with primary gastric diffuse large B-cell lymphoma stratified by no chemotherapy, and chemotherapy with COP and CHOP, respectively. Journal of the Formosan Medical Association 2013 112, 382-389DOI: (10.1016/j.jfma.2012.07.031) Copyright © 2012 Terms and Conditions
Figure 2 (A) Progression-free survival and (B) overall survival of patients with primary gastric diffuse large B-cell lymphoma. Journal of the Formosan Medical Association 2013 112, 382-389DOI: (10.1016/j.jfma.2012.07.031) Copyright © 2012 Terms and Conditions
Figure 3 A representative case of primary gastric lymphoma. (A) and (C) Gross and microscopic scanning power showing a polypoid tumorous lesion with transmural infiltration of lymphoma cells. (B) High-power view shows diffuse infiltration of large lymphoma cells with centroblastic morphology and gastric epithelial cells at the left-lower corner. The tumor cells express bcl-6 (F) but not CD10 (D), bcl-2 (E) or MUM1 (G), a GCB phenotype by Hans algorithm and type 1 by Muris algorithm. Journal of the Formosan Medical Association 2013 112, 382-389DOI: (10.1016/j.jfma.2012.07.031) Copyright © 2012 Terms and Conditions